Keywords

• Apixaban
• 503612-47-3
• Pharmaceutical Chemicals

Quick Details

• ProName: Hotsale Apixaban with high quality
• CasNo: 503612-47-3
• Molecular Formula: C10H16N2O4S3.HCl
• Appearance: White powder
• Application: Apixaban (INN, trade name Eliquis) is ...
• DeliveryTime: 3days
• PackAge: 10g/pack,100g/pack,1kg/pack
• Port: Shanghai port
• ProductionCapacity: 10000 Kilogram/Year
• Purity: 99%min
• Storage: storage in a dry, ventilated place und...
• Transportation: BY EMS,FEDEX,AIR
• LimitNum: 1 Gram
• Valid Period: 2years
• Batch: 20150302

Superiority

1,In No Less five years exporting experience.

2.Lower Price with higher quality

3,Free sample

4,We are sincerely responsible for the "product quality" and "After Service"

Details

Company Introduction:

Onchem (China) Co.,Ltd  is a comprehensive manufacturer and an international distribution of chemicals throughout the world. Specialized in APIs, chemical intermediates, herbal extract and pharmaceutical raw materials. 

ProName:Apixaban
IUPAC:1-(4-methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5-dihydropyrazolo[5,4-c]pyridine-3-carboxamide
Bioavailability:ca. 50%
Half-life:9–14 h
Excretion:75% biliary, 25% renally
CAS number:503612-47-3 
ATC code:B01A
PubChem:CID 10182969
DrugBank:DB07828
ChemSpider:8358471 
UNII:3Z9Y7UWC1J 
KEGG:D03213
ChEMBL:CHEMBL231779 
Formula:C25H25N5O4 
Mol. mass:459.497 g/mol
InChI:InChI=1S/C25H25N5O4/c1-34-19-11-9-18(10-12-19)30-23-20(22(27-30)24(26)32)13-15-29(25(23)33)17-7-5-16(6-8-17)28-14-3-2-4-21(28)31/h5-12H,2-4,13-15H2,1H3,(H2,26,32)

Product information:
Apixaban (INN, trade name Eliquis) is an anticoagulant for the prevention of venous thromboembolism and the prevention of stroke in atrial fibrillation.
Apixaban is a factor Xa inhibitor (anticoagulant) indicated to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation. A systematic review of new anticoagulants states the treatment benefits of apixaban and other new anticoagulants compared with warfarin are small and vary depending on the control achieved by warfarin treatment. Patients already taking warfarin with excellent international normalized ratio (INR) control may have little to gain by switching to new oral anticoagulants in atrial fibrillation.

Welcome to Onchem (China) Co.,Ltd, and welcome to inquiry me about all our products, we will provice the competitive price for u. We are sincerely responsible for the "product quality" and "After Service"